# Post-COVID-19 Chronic Fatigue Syndrome

> **NCT05642923** · PHASE4 · COMPLETED · sponsor: **ClinAmygate** · enrollment: 528 (actual)

## Conditions studied

- Post-COVID-19 Syndrome
- Post-COVID Syndrome

## Interventions

- **DRUG:** Synthetic Vitamin B1

## Key facts

- **NCT ID:** NCT05642923
- **Lead sponsor:** ClinAmygate
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-08
- **Primary completion:** 2024-06-01
- **Final completion:** 2025-03-05
- **Target enrollment:** 528 (ACTUAL)
- **Last updated:** 2025-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05642923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05642923, "Post-COVID-19 Chronic Fatigue Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05642923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*